Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-13
1989-08-01
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, 548252, 514561, 514562, 514570, 514571, 562426, 562429, 562430, 562434, 562460, 562463, 560 9, 560 11, 560 12, 560 18, 560 45, 560 46, 560 52, 560 53, 560 57, 560 65, 560 67, 560 70, C07D25704, A61K 3141, A61K 3119, C07C 5948
Patent
active
048533980
ABSTRACT:
This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
REFERENCES:
patent: 3899513 (1975-08-01), Warren et al.
patent: 4281008 (1981-07-01), Chamberlain et al.
patent: 4424231 (1984-01-01), Bantick et al.
patent: 4474788 (1984-10-01), Bantick
patent: 4499299 (1985-02-01), Bernstein et al.
patent: 4567279 (1986-01-01), Chan
patent: 4617407 (1986-10-01), Young et al.
patent: 4628115 (1986-12-01), Carson et al.
patent: 4644071 (1987-02-01), Masatern et al.
patent: 4650812 (1987-03-01), Cohen et al.
Carr F. P.
Dillard Robert D.
McCullough Doris E.
Conrad Robert A.
Eli Lilly and Company
Springer David B.
Whitaker Leroy
LandOfFree
Leukotriene antagonists and use thereas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists and use thereas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists and use thereas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-131775